Evaluation of SARS-CoV-2 infection risks after primary vaccination with BNT162b2, BBIBP-CorV, or ChAdOx1-nCOV-19 and after homologous and heterologous booster vaccinations with these vaccines and evaluation of SARS-CoV-2 reinfection profiles
-
Published:2023-08-28
Issue:3
Volume:13
Page:31-48
-
ISSN:2211-8039
-
Container-title:BioMedicine
-
language:en
-
Short-container-title:BioMedicine
Author:
Djorwé Soulandi,Bousfiha Amale,Nzoyikorera Néhémie,Nyandwi Joseph,Kawthar Bellamine,Malki Abderrahim
Publisher
China Medical University
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine